PubRank

Rosaria Talarico

Author PubWeight™ 20.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. J Rheumatol 2012 2.27
2 Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 2011 1.46
3 Systemic vasculitis: an annual critical digest of the most recent literature. Clin Exp Rheumatol 2014 1.42
4 Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol 2013 1.41
5 Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am 2010 1.26
6 "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 2011 1.15
7 Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: a retrospective study. J Rheumatol 2010 1.12
8 Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev 2010 1.00
9 Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy. Clin Rheumatol 2009 0.90
10 Behçet's syndrome: a critical digest of the 2013-2014 literature. Clin Exp Rheumatol 2014 0.86
11 A systematic literature review of the economic impact of ankylosing spondylitis. Clin Exp Rheumatol 2012 0.85
12 A clinical prediction rule for lymphoma development in primary Sjögren's syndrome. J Rheumatol 2012 0.83
13 Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? Rheumatol Int 2013 0.81
14 Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease. Medicine (Baltimore) 2015 0.81
15 The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management. Expert Rev Clin Immunol 2013 0.81
16 Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 2012 0.79
17 Analysis of the evolution of UCTD to defined CTD after a long term follow-up. Clin Exp Rheumatol 2012 0.78
18 Successful treatment of refractory adult-onset still disease with canakinumab: a case report. J Clin Rheumatol 2014 0.77
19 Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. Clin Exp Rheumatol 2012 0.75
20 Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort. Medicine (Baltimore) 2015 0.75
21 Ultrasound imaging for the rheumatologist XLV. Ultrasound of the shoulder in psoriatic arthritis. Clin Exp Rheumatol 2013 0.75
22 Behçet's disease and other autoinflammatory conditions: a brief account of a decade. Clin Exp Rheumatol 2010 0.75
23 Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. Clin Exp Rheumatol 2013 0.75
24 Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews. Clin Rheumatol 2008 0.75
25 Self-criticism in Behçet's disease and other autoinflammatory conditions. Clin Exp Rheumatol 2014 0.75